Provista Diagnostics

Provista Diagnostics

Biotechnology, 55 Broad St, Alpharetta, Georgia, 10004, United States, 11-50 Employees

provistadx.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: +14*********

Who is PROVISTA DIAGNOSTICS

Provista Diagnostics, your neighborhood early detection center based in Alpharetta, GA, is simplifying health diagnostics. Provista is creating empowering diagnostics for Women's Health h...

Read More

map
  • 55 Broad St, Alpharetta, Georgia, 10004, United States Headquarters: 55 Broad St, Alpharetta, Georgia, 10004, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5311 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PROVISTA DIAGNOSTICS

Provista Diagnostics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Provista Diagnostics

Answer: Provista Diagnostics's headquarters are located at 55 Broad St, Alpharetta, Georgia, 10004, United States

Answer: Provista Diagnostics's phone number is +14*********

Answer: Provista Diagnostics's official website is https://provistadx.com

Answer: Provista Diagnostics's revenue is $5 Million to $10 Million

Answer: Provista Diagnostics's SIC: 5311

Answer: Provista Diagnostics's NAICS: 621511

Answer: Provista Diagnostics has 11-50 employees

Answer: Provista Diagnostics is in Biotechnology

Answer: Provista Diagnostics contact info: Phone number: +14********* Website: https://provistadx.com

Answer: Provista Diagnostics, your neighborhood early detection center based in Alpharetta, GA, is simplifying health diagnostics. Provista is creating empowering diagnostics for Women's Health helping patients and clinicians make better clinical decisions for the enhancement of health and quality of life. Provista is investing 100% of our COVID-19 PCR testing profits in creating life-saving diagnostic solutions for a healthier today and tomorrow with Videssa Breast Cancer Detection being launched first as early as 4thQ 2022.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access